C M Bidwell & Associates LTD Pacira Bio Sciences, Inc. Transaction History

C M Bidwell & Associates LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$50.47 - $66.26 $237,209 - $311,422	-4,700 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$51.97 - $63.0 $244,259 - $296,100	4,700 New	4,700 $283,000
Q2 2020 Aug 14, 2020	SELL	$30.8 - $52.47 $26,950 - $45,911	-875 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$28.4 - $50.7 $24,850 - $44,362	875 New	875 $29,000
Q3 2019 Nov 13, 2019	SELL	$35.66 - $44.99 $36,373 - $45,889	-1,020 Closed	0 $0
Q2 2019 Aug 07, 2019	BUY	$36.57 - $47.97 $37,301 - $48,929	1,020 New	1,020 $44,000

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of C M Bidwell & Associates LTD, based on Form 13F filings with the SEC.

Stay updated on C M Bidwell & Associates LTD with notifications on news.